Health economics of exome sequencing for rare disorders.

Deborah Schofield

Research output: Contribution to journalMeeting abstract

Abstract

Rare genetic disorders can have devastating health impacts on patients. A sometimes overlooked area of significant impact is the cost of the disorders. The results of a study of the relative cost of exome sequencing compared to usual care are presented, along with a review of the breadth of the costs of monogenic childhood disorders both within and beyond the health system.
Original languageEnglish
Pages (from-to)S32
Number of pages1
JournalPathology
Volume48
Issue numberS1
DOIs
Publication statusPublished - Feb 2016
Externally publishedYes
EventPathology Update (2016) - Victoria, Australia
Duration: 26 Feb 201628 Feb 2016

Fingerprint Dive into the research topics of 'Health economics of exome sequencing for rare disorders.'. Together they form a unique fingerprint.

Cite this